We are live on
!
Find out more
SCM
Semanteon Capital Management Portfolio holdings
AUM
$7.45M
1-Year Est. Return
55.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.57%
1 Year Est. Return
+55.81%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$147M
AUM Growth
+$5.37M
(+3.8%)
Cap. Flow
-$676K
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
8.42%
Holding
324
New
125
Increased
33
Reduced
40
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NovoCure
NVCR
|
+$1.34M |
| 2 |
Ovintiv
OVV
|
+$1.29M |
| 3 |
Halliburton
HAL
|
+$1.28M |
| 4 |
NOV
NOV
|
+$1.28M |
| 5 |
Power Integrations
POWI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADMA Biologics
ADMA
|
+$1.24M |
| 2 |
Lumentum
LITE
|
+$1.23M |
| 3 |
Q2 Holdings
QTWO
|
+$1.23M |
| 4 |
A10 Networks
ATEN
|
+$1.22M |
| 5 |
First Financial Bankshares
FFIN
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.44% |
| 2 | Technology | 16.39% |
| 3 | Consumer Discretionary | 14.32% |
| 4 | Healthcare | 14.31% |
| 5 | Materials | 9.63% |
Similar funds
AL
MS
PCM
CCP
GCM
SA
OFC
LA
Semanteon Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Semanteon Capital Management held 324 positions worth $147M, up 3.8% from $141M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Semanteon Capital Management's Q3 2024 filing shows 125 new, 33 increased, 40 reduced and 125 closed positions. Its largest new stake was NovoCure: 73,729 shares worth $1.15M. The largest sale was ADMA Biologics, an estimated $1.24M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Semanteon Capital Management's largest Q3 2024 buy was NovoCure: 73,729 shares worth $1.15M.
- Semanteon Capital Management added most to Strategic Education in Q3 2024, an estimated $1.07M increase.
- Semanteon Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $1.13M.
- Semanteon Capital Management fully exited ADMA Biologics in Q3 2024, selling an estimated $1.24M.
- Semanteon Capital Management's ten largest holdings make up 8.4% of its $147M portfolio in Q3 2024.
- Semanteon Capital Management opened 125 new positions and closed 125 in Q3 2024.
- Semanteon Capital Management's portfolio value rose 3.8% quarter-over-quarter to $147M.
Based on Semanteon Capital Management's 13F filing for Q3 2024, filed 24 Oct 2024.